Stay updated on OMS721 Compassionate Use in TMA Clinical Trial
Sign up to get notified when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.

Latest updates to the OMS721 Compassionate Use in TMA Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record for OMS721 compassionate use in patients with thrombotic microangiopathy is displayed, including its study details, participation criteria, intervention, and contact information.SummaryDifference27%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA site-wide NIH notice about terminology changes was added, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error (with a Home link), replacing the previous study record content and removing the study-related details.SummaryDifference14%

- Check60 days agoChange DetectedUI copy guiding users to contact information was updated to 'Find contact information' (lowercase c). The site revision was bumped to v3.7.0 from v3.6.6, indicating a minor release.SummaryDifference0.2%

Stay in the know with updates to OMS721 Compassionate Use in TMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.